David C. Henderson, MD
- 28Articles
- 70.6KReads
- 1998–2021Active
- 51Collaborators
- 111Citations
About
David C. Henderson, MD, affiliated with the Department of Psychiatry at Boston University School of Medicine and Boston Medical Center, has contributed extensively to research on schizophrenia and schizoaffective disorders, with a focus on psychopharmacology and associated metabolic complications. His publications address clinical topics such as antipsychotic treatment effects, metabolic and weight changes related to atypical antipsychotics, insulin resistance, and comorbid conditions including addiction and dementia. Henderson’s work spans from 1998 to 2021 and includes collaborative studies on cognitive function, cardiovascular risks, and glucose metabolism in psychiatric populations.
Publications
Paliperidone LAI vs Oral Antipsychotics in African American Patients With Criminal Justice System Involvement
February 23, 2021
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
